ERBB2 and neoplasm: Estrogen receptors (ER), progesterone receptors (PR), or human epidermal growth factor receptor 2 (HER2) expression has significant implications for prognosis and the selection of therapeutic modalities and is routinely used for tumor classification (4, 5).